Disappointments Not Slowing Biotech IPOs


The market for new biotechnology shares has seen several disappointing debuts and delays, but experts predict that biotechs with the right ingredients will continue to make their public debuts...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99